Ryan Smith shares how TruDiagnostic is using AI and DNA methylation to measure biological age, predict chronic disease, and transform longevity medicine.
----
In this episode, I talk with Ryan Smith about how TruDiagnostic is leading a revolution in longevity. We dive into the power of epigenetic clocks, AI modeling, and personalized diagnostics to predict chronic disease, assess biological age, and identify what really works—from hyperbaric oxygen to Vitamin D. Ryan explains how epigenetic reprogramming and new CRISPR-style therapies may finally unlock true longevity escape velocity.
----
Ryan Smith is the founder of TruDiagnostic and a pioneer in the field of epigenetics and longevity medicine. From his early breakthroughs in peptide science to launching one of the most advanced biological age testing platforms in the world, Ryan has been at the forefront of personalized health innovation. His work is transforming how we diagnose, track, and treat aging itself, making the science of living younger, longer, and more accessible to patients and clinicians alike.
----
PODCAST
Thank you for listening.
Please subscribe and share.
This podcast is produced by DrTalks.com https://drtalks.com/podcast-service/
----
Disclaimer
*Richard Handley earned his MD degree (summa cum laude) and is licensed and board-certified as a PA-C in California, with active NPI and DEA registration. He does not practice as a physician. All content is for educational purposes only and is not a substitute for professional medical advice. Always consult your personal healthcare provider before making healthcare decisions.
